Icon

VEPESID (nda018768)- (20MG/ML)

ETOPOSIDE CORDEN PHARMA
20MG/ML
No No
Expired Expired
None None
None No
VePesid (etoposide) is indicated in the management of the following neoplasms: *Refractory Testicular Tumors—VePesid For Injection in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. *Small Cell Lung Cancer—VePesid For Injection and/or Capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer.
4 0 4
Total Other Developers None
Drugs with Suitability No
20MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ********** **** ********* *********** ************ **, **********, ***** ****** *****, ******* (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** *. **** ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.